These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 8163047
1. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Engerman RL, Kern TS, Larson ME. Diabetologia; 1994 Feb; 37(2):141-4. PubMed ID: 8163047 [Abstract] [Full Text] [Related]
2. Aldose reductase and the development of renal disease in diabetic dogs. Kern TS, Engerman RL. J Diabetes Complications; 1999 Feb; 13(1):10-6. PubMed ID: 10232704 [Abstract] [Full Text] [Related]
3. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, Liang KY, Gabbay KH, Rubenstein AH, Porte D. N Engl J Med; 1983 Jan 20; 308(3):119-25. PubMed ID: 6401351 [Abstract] [Full Text] [Related]
4. Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia. Engerman RL, Kern TS, Larson ME. Metabolism; 1990 Jun 20; 39(6):638-40. PubMed ID: 2352480 [Abstract] [Full Text] [Related]
6. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Engerman RL, Kern TS. Diabetes; 1993 Jun 20; 42(6):820-5. PubMed ID: 8495805 [Abstract] [Full Text] [Related]
7. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Yue DK, Hanwell MA, Satchell PM, Turtle JR. Diabetes; 1982 Sep 20; 31(9):789-94. PubMed ID: 6819173 [Abstract] [Full Text] [Related]
8. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats. Kato N, Mizuno K, Makino M, Suzuki T, Yagihashi S. Diabetes Res Clin Pract; 2000 Oct 20; 50(2):77-85. PubMed ID: 10960717 [Abstract] [Full Text] [Related]
10. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H, Tawata M, Aida K, Onaya T. J Clin Endocrinol Metab; 1992 Feb 20; 74(2):393-8. PubMed ID: 1370506 [Abstract] [Full Text] [Related]
15. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ. FASEB J; 2002 Jan 20; 16(1):123-5. PubMed ID: 11709499 [Abstract] [Full Text] [Related]